| RPRX Stock | | | USD 25.85 0.15 0.58% |
Royalty Pharma financial indicator trend analysis is much more than just breaking down Royalty Pharma Plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Royalty Pharma Plc is a good investment. Please check the relationship between Royalty Pharma Other Current Assets and its Accounts Payable accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Royalty Pharma Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
Other Current Assets vs Accounts Payable
Other Current Assets vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Royalty Pharma Plc Other Current Assets account and
Accounts Payable. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Royalty Pharma's Other Current Assets and Accounts Payable is 0.17. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Royalty Pharma Plc, assuming nothing else is changed. The correlation between historical values of Royalty Pharma's Other Current Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Royalty Pharma Plc are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Other Current Assets i.e., Royalty Pharma's Other Current Assets and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.17 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.
Accounts Payable
An accounting item on the balance sheet that represents Royalty Pharma obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Royalty Pharma Plc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Royalty Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Royalty Pharma Plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Royalty Pharma Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
At this time, Royalty Pharma's
Selling General Administrative is fairly stable compared to the past year.
Issuance Of Capital Stock is expected to grow at the current pace this year, whereas
Sales General And Administrative To Revenue is likely to drop 0.06 in 2024.
Royalty Pharma fundamental ratios Correlations
Click cells to compare fundamentals
Royalty Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Royalty Pharma fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Royalty Stock Analysis
When running Royalty Pharma's price analysis, check to
measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to
predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.